NTHI

NeOnc Technologies Holdings is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. The company is advancing neoadjuvant and adjuvant oncology programs targeting solid tumors with novel mechanisms designed to improve patient outcomes in challenging cancer indications.